NO964775L - Solid pharmaceutical adenosine-containing preparation - Google Patents

Solid pharmaceutical adenosine-containing preparation

Info

Publication number
NO964775L
NO964775L NO964775A NO964775A NO964775L NO 964775 L NO964775 L NO 964775L NO 964775 A NO964775 A NO 964775A NO 964775 A NO964775 A NO 964775A NO 964775 L NO964775 L NO 964775L
Authority
NO
Norway
Prior art keywords
solid pharmaceutical
adenosine
containing preparation
preparation
methyladenosine
Prior art date
Application number
NO964775A
Other languages
Norwegian (no)
Other versions
NO964775D0 (en
Inventor
Fulvio Gadient
Maria Milavec
Else Mueller
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919116212A external-priority patent/GB9116212D0/en
Publication of NO964775L publication Critical patent/NO964775L/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to NO964775A priority Critical patent/NO964775D0/en
Publication of NO964775D0 publication Critical patent/NO964775D0/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører et fast farmasøytisk preparat for oral tilførsel, som inneholder 6-cykloheksyl-2'-0-metyladenosin- hydrat. Preparatet kan foreligge i enhetsdoseform, i form av en tablett eller i form av en kapsel.This invention relates to a solid pharmaceutical composition for oral administration containing 6-cyclohexyl-2'-O-methyladenosine hydrate. The preparation may be in unit dosage form, in the form of a tablet or in the form of a capsule.

NO964775A 1991-07-26 1996-11-11 Solid pharmaceutical adenosine-containing preparation NO964775D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO964775A NO964775D0 (en) 1991-07-26 1996-11-11 Solid pharmaceutical adenosine-containing preparation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919116212A GB9116212D0 (en) 1991-07-26 1991-07-26 New use of organic compounds
NO92920564A NO920564L (en) 1991-07-26 1992-02-13 PHARMACEUTICAL ADENOS-CONTAINING PREPARATIONS
NO964775A NO964775D0 (en) 1991-07-26 1996-11-11 Solid pharmaceutical adenosine-containing preparation

Publications (2)

Publication Number Publication Date
NO964775L true NO964775L (en) 1993-01-27
NO964775D0 NO964775D0 (en) 1996-11-11

Family

ID=27265780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964775A NO964775D0 (en) 1991-07-26 1996-11-11 Solid pharmaceutical adenosine-containing preparation

Country Status (1)

Country Link
NO (1) NO964775D0 (en)

Also Published As

Publication number Publication date
NO964775D0 (en) 1996-11-11

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
FI906245A0 (en) PREPARATION OF L-CARNITINE.
NO2000010I1 (en) Pharmaceutically acceptable salts of esomeprazole
NO330947B1 (en) The use of oxcarbazepine-containing pharmaceutical compositions in the fasted state
ES488168A0 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT.
BR0003158A (en) Instant melting oral dosage formulation
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
IT8423523A0 (en) PROCEDURE AND COMPOSITION FOR THE PREPARATION OF CONTROLLED LONG-ACTING PHARMACEUTICAL PRODUCTS FOR ORAL ADMINISTRATION.
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
DE69425932D1 (en) Rapidly dissolving pharmaceutical dosage forms and methods for their manufacture
DE60126433D1 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
GR890100834A (en) Pyridine derivatives their production and use
IL103329A0 (en) Imidazole-5-carboxylic acid acylals,their preparation and pharmaceutical compositions containing them
NO302368B1 (en) Quinoxaline compounds, pharmaceutical compositions containing them, and use of the compounds for the preparation of the preparations
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
ATE13488T1 (en) GALLIUM CHLORIDE, A NEW ANTI-CANCER AGENT.
MX9203615A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF POWDER FOR NASAL ADMINISTRATION.
NO964775L (en) Solid pharmaceutical adenosine-containing preparation
IT8319219A0 (en) ARYLOXYPROPANOLAMINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS WHICH THEY CONTAIN AND THEIR THERAPEUTIC USE
GEP20043377B (en) Pharmaceutical Complex
YU81101A (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
DK0483320T3 (en) Prolonged-release pharmaceutical compositions for oral administration and methods for their preparation